The emergence of mephedrone and also other artificial cathinones has presented worries for lawmakers and regulatory organizations tasked with controlling the proliferation of latest psychoactive substances. The dynamic mother nature of artificial drug creation, coupled with the flexibility of chemists to switch molecular structures to evade legal l